In pathogenic conditions, such as the presence of a RUNX-MACROD1 fusion protein that was identified in leukaemia [99], the protein likely also localises to the nucleus instead of the mitochondria, as the RUNX fusion will mask the mitochondrial targeting sequence, comparable to the localisation after labelling with an N-terminal GFP tag. Here, MACROD1 is linked to leukemia.